Extension of Expiration Date for Endocrine Disorders Body System Listings, 23579-23581 [2018-10867]
Download as PDF
<![CDATA[
amozie on DSK3GDR082PROD with RULES
Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations
(b) It will monitor firms to which
relief is granted for compliance with the
regulatory requirements for which
substituted compliance is accepted and
will promptly notify the Commission or
NFA of any change in status of a firm
that would affect its continued
eligibility for the exemption granted
hereunder, including the termination of
its activities in the U.S.;
(c) All transactions with respect to
customers located in the U.S. will be
made subject to the regulations of NSE;
(d) It will provide the Commission
with prompt notice of all material
changes to the relevant laws in India,
any rules promulgated thereunder, and
NSE rules, including, but not limited to
NSE’s authorization, licensure or
registration, as applicable;
(e) Customers located in the U.S. will
be provided no less stringent regulatory
protection than India customers under
all relevant provisions of Indian law;
and
(f) It will cooperate with the
Commission with respect to any
inquiries concerning any activity subject
to regulation under the part 30
Regulations, including sharing the
information specified in Appendix A on
an ‘‘as needed’’ basis and will use its
best efforts to notify the Commission if
it becomes aware of any information
that in its judgment affects the financial
or operational viability of a member
firm doing business in the U.S. under
the exemption granted by this Order.
(2) Each firm seeking relief hereunder
must represent in writing that it:
(a) Is located outside the U.S., its
territories and possessions and, where
applicable, has subsidiaries or affiliates
domiciled in the U.S. with a related
business (e.g., banks and broker/dealer
affiliates) along with a brief description
of each subsidiary’s or affiliate’s identity
and principal business in the U.S.;
(b) Consents to jurisdiction in the U.S.
under the Act by filing a valid and
binding appointment of an agent in the
U.S. for service of process in accordance
with the requirements set forth in
Regulation 30.5;
(c) Agrees to provide access to its
books and records related to
transactions under part 30 required to
be maintained under the applicable
statutes and regulations in effect in
India upon the request of any
representative of the Commission or
U.S. Department of Justice at the place
in the U.S. designated by such
representative, within 72 hours, or such
lesser period of time as specified by that
representative as may be reasonable
under the circumstances after notice of
the request;
VerDate Sep<11>2014
15:59 May 21, 2018
Jkt 244001
(d) Has no principal or employee who
solicits or accepts orders from
customers located in the U.S. who
would be disqualified under Section
8a(2) of the Act, 7 U.S.C. 12a(2), from
doing business in the U.S.;
(e) Consents to participate in any NFA
arbitration program that offers a
procedure for resolving customer
disputes on the papers where such
disputes involve representations or
activities with respect to transactions
under part 30, and consents to notify
customers located in the U.S. of the
availability of such a program; provided,
however, that the firm may require its
customers located in the U.S. to execute
a consent concerning the exhaustion of
certain mediation or conciliation
procedures made available by NSE prior
to bringing an NFA arbitration
proceeding; and
(f) Undertakes to comply with the
applicable provisions of Indian laws
and NSE rules that form the basis upon
which this exemption from certain
provisions of the Act and regulations
thereunder is granted.
As set forth in the Commission’s
September 11, 1997 Order delegating to
NFA certain responsibilities, the written
representations set forth in paragraph
(2) shall be filed with NFA.8 Each firm
seeking relief hereunder has an ongoing
obligation to notify NFA should there be
a material change to any of the
representations required in the firm’s
application for relief.
This Order will become effective as to
any designated NSE firm the later of the
date of publication of the Order in the
Federal Register or the filing of the
consents set forth in paragraphs (2)(a)–
(f). Upon filing of the notice required
under paragraph (1)(b) as to any such
firm, the relief granted by this Order
may be suspended immediately as to
that firm. That suspension will remain
in effect pending further notice by the
Commission, or the Commission’s
designee, to the firm and NSE.
This Order is issued pursuant to
Regulation 30.10 based on the
representations made and supporting
material provided to the Commission
and the recommendation of the staff,
and is made effective as to any firm
granted relief hereunder based upon the
filings and representations of such firms
required hereunder. Any material
changes or omissions in the facts and
8 62 FR 47792, 47793 (Sept. 11, 1997). Among
other duties, the Commission authorized NFA to
receive requests for confirmation of Regulation
30.10 relief on behalf of particular firms, to verify
such firms’ fitness and compliance with the
conditions of the appropriate Regulation 30.10
Order and to grant exemptive relief from
registration to qualifying firms.
PO 00000
Frm 00005
Fmt 4700
Sfmt 4700
23579
circumstances pursuant to which this
Order is granted might require the
Commission to reconsider its finding
that the standards for relief set forth in
Regulation 30.10 and, in particular,
Appendix A, have been met. Further, if
experience demonstrates that the
continued effectiveness of this Order in
general, or with respect to a particular
firm, would be contrary to public policy
or the public interest, or that the
systems in place for the exchange of
information or other circumstances do
not warrant continuation of the
exemptive relief granted herein, the
Commission may condition, modify,
suspend, terminate, withhold as to a
specific firm, or otherwise restrict the
exemptive relief granted in this Order,
as appropriate, on its own motion.
The Commission will continue to
monitor the implementation of its
program to exempt firms located in
jurisdictions generally deemed to have a
comparable regulatory program from the
application of certain of the foreign
futures and option regulations and will
make necessary adjustments if
appropriate.
Issued in Washington, DC, on May 17,
2018, by the Commission.
Robert Sidman,
Deputy Secretary of the Commission.
Appendix to Foreign Futures and
Options Transactions—Commission
Voting Summary
On this matter, Chairman Giancarlo and
Commissioners Quintenz and Behnam voted
in the affirmative. No Commissioner voted in
the negative.
[FR Doc. 2018–10902 Filed 5–21–18; 8:45 am]
BILLING CODE 6351–01–P
SOCIAL SECURITY ADMINISTRATION
20 CFR Part 404
[Docket No. SSA–2018–0016]
RIN 0960–AI28
Extension of Expiration Date for
Endocrine Disorders Body System
Listings
Social Security Administration.
Final rule.
AGENCY:
ACTION:
We are extending the
expiration date of Endocrine Disorders
body system in the Listing of
Impairments (listings) in our
regulations. We are making no other
revisions to the body system in this final
rule. This extension ensures that we
will continue to have the criteria we
need to evaluate impairments in the
affected body system at step three of the
SUMMARY:
E:\FR\FM\22MYR1.SGM
22MYR1
23580
Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations
sequential evaluation processes for
initial claims and continuing disability
reviews.
This final rule is effective May
22, 2018.
DATES:
FOR FURTHER INFORMATION CONTACT:
Cheryl A. Williams, Director, Office of
Medical Policy, 6401 Security
Boulevard, Baltimore, MD 21235–6401,
(410) 965–1020. For information on
eligibility or filing for benefits, call our
national toll-free number, 1–800–772–
1213, or TTY 1–800–325–0778, or visit
our internet site, Social Security Online,
at https://www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
Background
We use the listings in appendix 1 to
subpart P of part 404 of 20 CFR at the
third step of the sequential evaluation
process to evaluate claims filed by
adults and children for benefits based
on disability under the title II and title
XVI programs.1 20 CFR 404.1520(d),
416.920(d), 416.924(d). The listings are
in two parts: Part A has listings criteria
for adults and Part B has listings criteria
for children. If you are age 18 or over,
we apply the listings criteria in Part A
when we assess your impairment or
combination of impairments. If you are
under age 18, we first use the criteria in
Part B of the listings when we assess
your impairment(s). If the criteria in
Part B do not apply, we may use the
criteria in Part A when those criteria
consider the effects of your
impairment(s). 20 CFR 404.1525(b),
416.925(b).
Explanation of Changes
In this final rule, we are extending the
date on which the Endocrine Disorders
body system will no longer be effective
as set out in the following chart:
Body system
Current
expiration date
Endocrine Disorders (9.00 and 109.00) ............................................................................................................
June 8, 2018 ....
We continue to revise and update the
listings on a regular basis, including
those body systems not affected by this
final rule.2 We continue to evaluate the
treatment of disorders in the Endocrine
Disorders body system, and intend to
update the listing affected by this final
rule as necessary based on medical
advances. Therefore, we are extending
the expiration date listed above.
Regulatory Procedures
amozie on DSK3GDR082PROD with RULES
Justification for Final Rule
We follow the Administrative
Procedure Act (APA) rulemaking
procedures specified in 5 U.S.C. 553 in
promulgating regulations. Section
702(a)(5) of the Social Security Act, 42
U.S.C. 902(a)(5). Generally, the APA
requires that an agency provide prior
notice and opportunity for public
comment before issuing a final
regulation. The APA provides
exceptions to the notice-and-comment
requirements when an agency finds
there is good cause for dispensing with
such procedures because they are
impracticable, unnecessary, or contrary
to the public interest.
We determined that good cause exists
for dispensing with the notice and
public comment procedures. 5 U.S.C.
553(b)(B). This final rule only extends
the date on which the Endocrine
Disorders body system listings will no
longer be effective. It makes no
substantive changes to our rules. Our
current regulations 3 provide that we
may extend, revise, or promulgate the
body system listings again. Therefore,
1 We also use the listings in the sequential
evaluation processes we use to determine whether
a beneficiary’s disability continues. See 20 CFR
404.1594, 416.994, and 416.994a.
VerDate Sep<11>2014
15:59 May 21, 2018
Jkt 244001
we determined that opportunity for
prior comment is unnecessary, and we
are issuing this regulation as a final rule.
In addition, for the reasons cited
above, we find good cause for
dispensing with the 30-day delay in the
effective date of this final rule. 5 U.S.C.
553(d)(3). We are not making any
substantive changes to the Endocrine
Disorders body system listings. Without
an extension of the expiration date for
the Endocrine Disorders body system
listings, we will not have the criteria we
need to assess medical impairments in
the body system at step three of the
sequential evaluation processes. We
therefore find it is in the public interest
to make this final rule effective on the
publication date.
Executive Order 12866, as
Supplemented by Executive Order
13563
We consulted with the Office of
Management and Budget (OMB) and
determined that this final rule does not
meet the requirements for a significant
regulatory action under Executive Order
12866, as supplemented by Executive
Order 13563. Therefore, OMB did not
review it. We also determined that this
final rule meets the plain language
requirement of Executive Order 12866.
Regulatory Flexibility Act
2 Since we last extended the expiration dates of
the listings affected by this final rule in May 2016
(81 FR 32643), we published final rules revising the
medical criteria for evaluating respiratory disorders
(81 FR 37138 (2016)), neurological disorders (81 FR
Frm 00006
Fmt 4700
Sfmt 4700
June 26, 2020.
analysis is not required under the
Regulatory Flexibility Act, as amended.
Paperwork Reduction Act
These rules do not create any new or
affect any existing collections and,
therefore, do not require Office of
Management and Budget approval
under the Paperwork Reduction Act.
(Catalog of Federal Domestic Assistance
Program Nos. 96.001, Social SecurityDisability Insurance; 96.002, Social SecurityRetirement Insurance; 96.004, Social
Security-Survivors Insurance; 96.006,
Supplemental Security Income)
List of Subjects in 20 CFR Part 404
Administrative practice and
procedure, Blind, Disability benefits,
Old-age, Survivors and Disability
Insurance, Reporting and recordkeeping
requirements, Social Security.
Nancy Berryhill,
Acting Commissioner of Social Security.
For the reasons set out in the
preamble, we are amending appendix 1
to subpart P of part 404 of chapter III of
title 20 of the Code of Federal
Regulations as set forth below.
PART 404—FEDERAL OLD–AGE,
SURVIVORS AND DISABILITY
INSURANCE (1950– )
Subpart P—[Amended]
We certify that this final rule does not
have a significant economic impact on
a substantial number of small entities
because it affects only individuals.
Therefore, a regulatory flexibility
PO 00000
Extended
expiration date
1. The authority citation for subpart P
of part 404 continues to read as follows:
■
Authority: Secs. 202, 205(a)–(b) and (d)–
(h), 216(i), 221(a) and (h)–(j), 222(c), 223,
43048 (2016)), mental disorders (81 FR 66137
(2016)), and human immunodeficiency virus (HIV)
infection (81 FR 86915 (2016)).
3 See the first sentence of appendix 1 to
subpart P of part 404 of 20 CFR.
E:\FR\FM\22MYR1.SGM
22MYR1
Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations
225, and 702(a)(5) of the Social Security Act
(42 U.S.C. 402, 405(a)–(b) and (d)–(h), 416(i),
421(a) and (h)–(j), 422(c), 423, 425, and
902(a)(5)); sec. 211(b), Pub. L. 104–193, 110
Stat. 2105, 2189; sec. 202, Pub. L. 108–203,
118 Stat. 509 (42 U.S.C. 902 note).
2. Amend appendix 1 to subpart P of
part 404 by revising item 10 of the
introductory text before Part A to read
as follows:
■
Appendix 1 to Subpart P of Part 404—
Listing of Impairments
*
*
*
*
*
10. Endocrine Disorders (9.00 and 109.00):
June 26, 2020.
*
*
*
*
*
[FR Doc. 2018–10867 Filed 5–21–18; 8:45 am]
BILLING CODE 4191–02–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
33 CFR Part 117
[Docket No. USCG–2017–0460]
Drawbridge Operation Regulation;
Shrewsbury River, Sea Bright, New
Jersey
Coast Guard, DHS.
Notice of temporary deviation
from regulations; request for comments.
AGENCY:
ACTION:
The Coast Guard has issued a
temporary deviation from the operating
schedule that governs the Monmouth
County Highway Bridge (alternatively
referred to as the ‘‘Sea Bright Bridge’’ or
the ‘‘S–32 Bridge’’) across the
Shrewsbury River, mile 4.0, at Sea
Bright, New Jersey. This deviation will
test a proposed change to the
drawbridge operation schedule to
determine whether a permanent change
to the schedule is warranted. This
deviation will allow the bridge to
operate under an alternate schedule that
seeks to balance the seasonally high
volume of roadway traffic crossing the
bridge during peak hours with the
existing needs of marine traffic.
DATES: This deviation is effective from
9 a.m. on May 25, 2018, to 7 p.m. on
September 3, 2018.
Comments and related material must
reach the Coast Guard on or before
September 3, 2018.
ADDRESSES: You may submit comments
identified by docket number USCG–
2017–0460 using Federal eRulemaking
Portal at https://www.regulations.gov.
See the ‘‘Public Participation and
Request for Comments’’ portion of the
SUPPLEMENTARY INFORMATION section
amozie on DSK3GDR082PROD with RULES
SUMMARY:
VerDate Sep<11>2014
15:59 May 21, 2018
Jkt 244001
below for instructions on submitting
comments.
If
you have questions on this test
deviation, call or email Ms. Donna
Leoce, Project Officer, First Coast Guard
District, telephone 212–514–4332,
donna.d.leoce@uscg.mil.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
I. Background, Purpose and Legal Basis
On July 18, 2017, the Coast Guard
published a notice of proposed
rulemaking (NPRM) entitled,
‘‘Drawbridge Operation Regulation;
Shrewsbury River, Sea Bright, New
Jersey’’ in the Federal Register (82 FR
32777) soliciting comments on the
proposed rule through September 18,
2017. In addition, Commander (dpb),
First Coast Guard District published
Public Notice 1–155 dated July 28, 2017.
The Monmouth County Highway
Bridge, mile 4.0, across the Shrewsbury
River at Sea Bright, New Jersey, has a
vertical clearance of 15 feet at Mean
High Water and 17 feet at Mean Low
Water when the span is in the closed
position. Vertical clearance is unlimited
when the draw is open. Horizontal
clearance is 75 feet. Waterway users
include recreational vessels and a
limited number of commercial vessels
including tug/barge combinations.
The existing drawbridge regulation,
33 CFR 117.755, requires the draw of
the Monmouth County Highway Bridge
to open as follows:
The draw shall open on signal at all
times; except that, from May 15 through
September 30, on Saturday, Sunday and
holidays, between 9 a.m. and 7 p.m., the
draw need open only on the hour and
half hour.
This regulation has been in effect
since July 6, 2010. The owner of the
bridge, the Monmouth County Board of
Chosen Freeholders, requested a change
to the drawbridge operating regulations
given the increased volume of vehicular
traffic crossing the bridge associated
with the summer months. The increase
of vehicular traffic has resulted in
significant traffic congestion on either
side of the bridge during peak travel
hours. The owner of the bridge asserts
traffic congestion will be relieved
through reduction of required bridge
openings for vessels.
Monmouth County also requested that
from May 15 to September 30 the
modified operating regulations
presently encompassing Saturdays,
Sundays, and holidays be expanded to
include Fridays as well. Monmouth
County posited that starting the
modified weekend operating schedule
on Friday will allow for more efficient
PO 00000
Frm 00007
Fmt 4700
Sfmt 4700
23581
and economical operation of the bridge,
given the volume of vehicular traffic
crossing the bridge at the beginning of
the weekend.
The NPRM published in July 2017, if
made a Final Rule, would permanently
change the operating hours to allow the
Monmouth County Highway Bridge to
open as follows: The draw shall open on
signal at all times; except that, from May
15 through September 30, on Friday,
Saturday, Sunday and holidays,
between 9 a.m. and 7 p.m., the draw
need only open on the hour.
In response to the comments received,
follow-up meetings with Monmouth
County officials, and further review of
bridge logs and traffic counts, the Coast
Guard now proposes to test an alternate
schedule by adjusting the proposed rule
to allow the draw to open as follows:
The draw shall open on signal at all
times; except that, from the Friday
before Memorial Day through Labor
Day, on Friday, Saturday, Sunday and
holidays, between 9 a.m. and 7 p.m., the
draw need only open on the hour.
Before advancing the proposed rule to
a final rule, the Coast Guard supports
testing an alternate schedule for the
2018 boating season in order to better
assess safety concerns and further
compare roadway traffic counts versus
requests for bridge openings. Monmouth
County plans to record traffic counts
during the Memorial Day, July 4th, and
Labor Day time periods as well as
additional one-week periods in July and
August. Bridge tenders will also collect
boat traffic data. Data from this test and
further public comments will best
inform our final decision.
The Coast Guard will also inform the
users of the waterways through our
Local and Broadcast Notices to Mariners
of the change in operating schedule for
the bridge so that vessel operators can
arrange their transits to minimize any
impact caused by the temporary
deviation.
In accordance with 33 CFR 117.35(e),
the drawbridge must return to its regular
operating schedule immediately at the
end of the effective period of this
temporary deviation. This deviation
from the operating regulations is
authorized under 33 CFR 117.35.
II. Public Participation and Request for
Comments
We view public participation as
essential to effective rulemaking, and
will consider all comments and material
received during the comment period.
Your comment can help shape the
outcome of this rulemaking. If you
submit a comment, please include the
docket number for this rulemaking,
indicate the specific section of this
E:\FR\FM\22MYR1.SGM
22MYR1
]]>Agencies
[Federal Register Volume 83, Number 99 (Tuesday, May 22, 2018)]
[Rules and Regulations]
[Pages 23579-23581]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10867]
=======================================================================
-----------------------------------------------------------------------
SOCIAL SECURITY ADMINISTRATION
20 CFR Part 404
[Docket No. SSA-2018-0016]
RIN 0960-AI28
Extension of Expiration Date for Endocrine Disorders Body System
Listings
AGENCY: Social Security Administration.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: We are extending the expiration date of Endocrine Disorders
body system in the Listing of Impairments (listings) in our
regulations. We are making no other revisions to the body system in
this final rule. This extension ensures that we will continue to have
the criteria we need to evaluate impairments in the affected body
system at step three of the
[[Page 23580]]
sequential evaluation processes for initial claims and continuing
disability reviews.
DATES: This final rule is effective May 22, 2018.
FOR FURTHER INFORMATION CONTACT: Cheryl A. Williams, Director, Office
of Medical Policy, 6401 Security Boulevard, Baltimore, MD 21235-6401,
(410) 965-1020. For information on eligibility or filing for benefits,
call our national toll-free number, 1-800-772-1213, or TTY 1-800-325-
0778, or visit our internet site, Social Security Online, at https://www.socialsecurity.gov.
SUPPLEMENTARY INFORMATION:
Background
We use the listings in appendix 1 to subpart P of part 404 of 20
CFR at the third step of the sequential evaluation process to evaluate
claims filed by adults and children for benefits based on disability
under the title II and title XVI programs.\1\ 20 CFR 404.1520(d),
416.920(d), 416.924(d). The listings are in two parts: Part A has
listings criteria for adults and Part B has listings criteria for
children. If you are age 18 or over, we apply the listings criteria in
Part A when we assess your impairment or combination of impairments. If
you are under age 18, we first use the criteria in Part B of the
listings when we assess your impairment(s). If the criteria in Part B
do not apply, we may use the criteria in Part A when those criteria
consider the effects of your impairment(s). 20 CFR 404.1525(b),
416.925(b).
---------------------------------------------------------------------------
\1\ We also use the listings in the sequential evaluation
processes we use to determine whether a beneficiary's disability
continues. See 20 CFR 404.1594, 416.994, and 416.994a.
---------------------------------------------------------------------------
Explanation of Changes
In this final rule, we are extending the date on which the
Endocrine Disorders body system will no longer be effective as set out
in the following chart:
------------------------------------------------------------------------
Current expiration Extended expiration
Body system date date
------------------------------------------------------------------------
Endocrine Disorders (9.00 June 8, 2018........ June 26, 2020.
and 109.00).
------------------------------------------------------------------------
We continue to revise and update the listings on a regular basis,
including those body systems not affected by this final rule.\2\ We
continue to evaluate the treatment of disorders in the Endocrine
Disorders body system, and intend to update the listing affected by
this final rule as necessary based on medical advances. Therefore, we
are extending the expiration date listed above.
---------------------------------------------------------------------------
\2\ Since we last extended the expiration dates of the listings
affected by this final rule in May 2016 (81 FR 32643), we published
final rules revising the medical criteria for evaluating respiratory
disorders (81 FR 37138 (2016)), neurological disorders (81 FR 43048
(2016)), mental disorders (81 FR 66137 (2016)), and human
immunodeficiency virus (HIV) infection (81 FR 86915 (2016)).
---------------------------------------------------------------------------
Regulatory Procedures
Justification for Final Rule
We follow the Administrative Procedure Act (APA) rulemaking
procedures specified in 5 U.S.C. 553 in promulgating regulations.
Section 702(a)(5) of the Social Security Act, 42 U.S.C. 902(a)(5).
Generally, the APA requires that an agency provide prior notice and
opportunity for public comment before issuing a final regulation. The
APA provides exceptions to the notice-and-comment requirements when an
agency finds there is good cause for dispensing with such procedures
because they are impracticable, unnecessary, or contrary to the public
interest.
We determined that good cause exists for dispensing with the notice
and public comment procedures. 5 U.S.C. 553(b)(B). This final rule only
extends the date on which the Endocrine Disorders body system listings
will no longer be effective. It makes no substantive changes to our
rules. Our current regulations \3\ provide that we may extend, revise,
or promulgate the body system listings again. Therefore, we determined
that opportunity for prior comment is unnecessary, and we are issuing
this regulation as a final rule.
---------------------------------------------------------------------------
\3\ See the first sentence of appendix 1 to subpart P of part
404 of 20 CFR.
---------------------------------------------------------------------------
In addition, for the reasons cited above, we find good cause for
dispensing with the 30-day delay in the effective date of this final
rule. 5 U.S.C. 553(d)(3). We are not making any substantive changes to
the Endocrine Disorders body system listings. Without an extension of
the expiration date for the Endocrine Disorders body system listings,
we will not have the criteria we need to assess medical impairments in
the body system at step three of the sequential evaluation processes.
We therefore find it is in the public interest to make this final rule
effective on the publication date.
Executive Order 12866, as Supplemented by Executive Order 13563
We consulted with the Office of Management and Budget (OMB) and
determined that this final rule does not meet the requirements for a
significant regulatory action under Executive Order 12866, as
supplemented by Executive Order 13563. Therefore, OMB did not review
it. We also determined that this final rule meets the plain language
requirement of Executive Order 12866.
Regulatory Flexibility Act
We certify that this final rule does not have a significant
economic impact on a substantial number of small entities because it
affects only individuals. Therefore, a regulatory flexibility analysis
is not required under the Regulatory Flexibility Act, as amended.
Paperwork Reduction Act
These rules do not create any new or affect any existing
collections and, therefore, do not require Office of Management and
Budget approval under the Paperwork Reduction Act.
(Catalog of Federal Domestic Assistance Program Nos. 96.001, Social
Security-Disability Insurance; 96.002, Social Security-Retirement
Insurance; 96.004, Social Security-Survivors Insurance; 96.006,
Supplemental Security Income)
List of Subjects in 20 CFR Part 404
Administrative practice and procedure, Blind, Disability benefits,
Old-age, Survivors and Disability Insurance, Reporting and
recordkeeping requirements, Social Security.
Nancy Berryhill,
Acting Commissioner of Social Security.
For the reasons set out in the preamble, we are amending appendix 1
to subpart P of part 404 of chapter III of title 20 of the Code of
Federal Regulations as set forth below.
PART 404--FEDERAL OLD-AGE, SURVIVORS AND DISABILITY INSURANCE
(1950- )
Subpart P--[Amended]
0
1. The authority citation for subpart P of part 404 continues to read
as follows:
Authority: Secs. 202, 205(a)-(b) and (d)-(h), 216(i), 221(a) and
(h)-(j), 222(c), 223,
[[Page 23581]]
225, and 702(a)(5) of the Social Security Act (42 U.S.C. 402,
405(a)-(b) and (d)-(h), 416(i), 421(a) and (h)-(j), 422(c), 423,
425, and 902(a)(5)); sec. 211(b), Pub. L. 104-193, 110 Stat. 2105,
2189; sec. 202, Pub. L. 108-203, 118 Stat. 509 (42 U.S.C. 902 note).
0
2. Amend appendix 1 to subpart P of part 404 by revising item 10 of the
introductory text before Part A to read as follows:
Appendix 1 to Subpart P of Part 404--Listing of Impairments
* * * * *
10. Endocrine Disorders (9.00 and 109.00): June 26, 2020.
* * * * *
[FR Doc. 2018-10867 Filed 5-21-18; 8:45 am]
BILLING CODE 4191-02-P
